Latest Insider Transactions at Cue Health Inc. (HLTH)
This section provides a real-time view of insider transactions for Cue Health Inc. (HLTH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cue Health Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cue Health Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 19
2022
|
Clint Sever Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,664
+0.66%
|
$0
$0.2 P/Share
|
|
Jun 28
2022
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,415
-1.82%
|
$37,245
$3.76 P/Share
|
|
Jun 24
2022
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,248
-0.25%
|
$120,992
$4.4 P/Share
|
|
Jun 24
2022
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
24,748
-0.62%
|
$98,992
$4.4 P/Share
|
|
Jun 06
2022
|
Christopher K Achar Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,327
-0.27%
|
$21,635
$5.3 P/Share
|
|
Jun 06
2022
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,996
-0.11%
|
$64,980
$5.3 P/Share
|
|
Jun 06
2022
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,548
-1.1%
|
$37,740
$5.3 P/Share
|
|
Jun 06
2022
|
Erica Palsis General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
5,948
-0.88%
|
$29,740
$5.3 P/Share
|
|
Jun 06
2022
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,633
-0.26%
|
$53,165
$5.3 P/Share
|
|
Mar 30
2022
|
Erica Palsis General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
214,812
+24.13%
|
-
|
|
Mar 30
2022
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
126,963
-1.04%
|
$761,778
$6.7 P/Share
|
|
Mar 30
2022
|
Ayub K Khattak President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
712,215
+2.86%
|
$2,136,645
$3.35 P/Share
|
|
Mar 30
2022
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99,772
-2.42%
|
$598,632
$6.7 P/Share
|
|
Mar 30
2022
|
Clint Sever Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
582,721
+6.81%
|
$1,748,163
$3.35 P/Share
|
|
Mar 30
2022
|
John E Gallagher Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
236,090
+25.51%
|
-
|
|
Mar 30
2022
|
Christopher K Achar Director |
BUY
Grant, award, or other acquisition
|
Direct |
139,635
+8.04%
|
-
|
|
Mar 28
2022
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,511
-2.69%
|
$75,066
$6.99 P/Share
|
|
Mar 24
2022
|
Ayub K Khattak President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
42,264
-0.36%
|
$253,584
$6.99 P/Share
|
|
Mar 24
2022
|
Clint Sever Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,754
-0.97%
|
$208,524
$6.99 P/Share
|
|
Feb 01
2022
|
Erica Palsis General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
38,912
-7.79%
|
$311,296
$8.78 P/Share
|
|
Dec 28
2021
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,452
-3.61%
|
$261,780
$15.66 P/Share
|
|
Sep 28
2021
|
John E Gallagher Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
66,379
-12.08%
|
$1,194,822
$18.63 P/Share
|
|
Sep 28
2021
|
Cove Investors I, LLC |
BUY
Conversion of derivative security
|
Indirect |
6,721,714
+35.19%
|
-
|
|
Sep 28
2021
|
Section 32 Fund 2, LP |
BUY
Conversion of derivative security
|
Direct |
3,485,535
+50.0%
|
-
|
|
Sep 28
2021
|
Sherpa Ventures Fund, LP |
BUY
Other acquisition or disposition
|
Indirect |
371,293
+6.33%
|
$4,455,516
$12.8 P/Share
|
|
Sep 28
2021
|
Sherpa Ventures Fund, LP |
BUY
Conversion of derivative security
|
Indirect |
14,545,868
+49.35%
|
-
|
|
Sep 28
2021
|
Scott Stanford |
BUY
Grant, award, or other acquisition
|
Indirect |
371,293
+6.33%
|
$4,455,516
$12.8 P/Share
|
|
Sep 28
2021
|
Scott Stanford |
BUY
Conversion of derivative security
|
Indirect |
14,545,868
+49.35%
|
-
|
|
Sep 28
2021
|
Xiangmin Cui |
BUY
Grant, award, or other acquisition
|
Indirect |
788,441
+50.0%
|
$9,461,292
$12.8 P/Share
|
|
Sep 28
2021
|
Xiangmin Cui |
BUY
Conversion of derivative security
|
Indirect |
8,192,468
+50.0%
|
-
|
|
Sep 28
2021
|
Decheng Capital China Life Sciences Usd Fund Iii, L.P. |
BUY
Conversion of derivative security
|
Direct |
8,192,468
+50.0%
|
-
|
|
Sep 28
2021
|
Christopher K Achar Director |
BUY
Conversion of derivative security
|
Direct |
69,710
+4.56%
|
-
|
|
Sep 24
2021
|
Clint Sever Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
798,636
+18.27%
|
-
|
|
Sep 24
2021
|
K Joanne Bradford Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Ayub K Khattak President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
976,111
+7.77%
|
-
|
|
Sep 24
2021
|
Maria Martinez Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Carole T Faig Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+50.0%
|
-
|
|
Sep 24
2021
|
Christopher K Achar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,388,246
+50.0%
|
-
|